Whitepaper

ASCO Reveals: Increasing Options for Relapse/ Refractory Patients in Haematological Malignancies
Hope for patients living with haematological malignancies; Immunotherapies represent a novel class of biologics
ASCO Reveals: Increasing Options for Relapse/ Refractory Patients in Haematological Malignancies

More Whitepapers / Newsletters

Gaucher Disease Newsletter
Gaucher Disease

The most common lysosomal disease, Gaucher Disease is a result of lack of sufficient glucocerebrosidase (GCase), an enzyme required..

An Abundance Of Rare Newsletter
An Abundance Of Rare

Though appear rare, rare diseases are far from being rare. With over 7,000 rare disease affecting millions worldwide.

Complex Regional Pain Syndrome Newsletter
Complex Regional Pain Syndrome

A chronic pain condition, Complex Regional Pain Syndrome (CRPS) often affects one limb and is believed to be caused by injury, or malfunction of..

Cancer Globally (Vol. 1, Issue 1) Newsletter
Cancer Globally (Vol. 1, Issue 1)

Cancer has gripped the human society in its clutches in such a way that there has been many advancements to treat the same, but with little success.

Impact of BREXIT on Pharma Space Newsletter
Impact of BREXIT on Pharma Space

BREXIT, the 'EXIT' of 'BRITAIN' from 'EUROPEAN UNION', shook the whole world when the United Kingdom voted in the favor of leaving the EU.